Talphera (TLPH) Competitors $1.17 -0.06 (-4.88%) Closing price 04:00 PM EasternExtended Trading$1.26 +0.09 (+7.61%) As of 06:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TLPH vs. CRBU, BDTX, TRDA, NLTX, EPRX, CLLS, CABA, TNXP, BIOA, and SLSShould you be buying Talphera stock or one of its competitors? The main competitors of Talphera include Caribou Biosciences (CRBU), Black Diamond Therapeutics (BDTX), Entrada Therapeutics (TRDA), Neoleukin Therapeutics (NLTX), Eupraxia Pharmaceuticals (EPRX), Cellectis (CLLS), Cabaletta Bio (CABA), Tonix Pharmaceuticals (TNXP), BioAge Labs (BIOA), and SELLAS Life Sciences Group (SLS). These companies are all part of the "pharmaceutical products" industry. Talphera vs. Its Competitors Caribou Biosciences Black Diamond Therapeutics Entrada Therapeutics Neoleukin Therapeutics Eupraxia Pharmaceuticals Cellectis Cabaletta Bio Tonix Pharmaceuticals BioAge Labs SELLAS Life Sciences Group Talphera (NASDAQ:TLPH) and Caribou Biosciences (NASDAQ:CRBU) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation and institutional ownership. Which has preferable valuation and earnings, TLPH or CRBU? Talphera has higher earnings, but lower revenue than Caribou Biosciences. Talphera is trading at a lower price-to-earnings ratio than Caribou Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTalphera$650K82.06-$13M-$0.40-2.93Caribou Biosciences$9.99M22.18-$149.10M-$1.78-1.34 Do analysts prefer TLPH or CRBU? Talphera currently has a consensus price target of $5.00, suggesting a potential upside of 327.35%. Caribou Biosciences has a consensus price target of $6.67, suggesting a potential upside of 180.11%. Given Talphera's stronger consensus rating and higher probable upside, equities analysts clearly believe Talphera is more favorable than Caribou Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Talphera 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.00Caribou Biosciences 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do insiders and institutionals hold more shares of TLPH or CRBU? 37.7% of Talphera shares are held by institutional investors. Comparatively, 77.5% of Caribou Biosciences shares are held by institutional investors. 5.7% of Talphera shares are held by company insiders. Comparatively, 9.5% of Caribou Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more volatility and risk, TLPH or CRBU? Talphera has a beta of 0.03, indicating that its share price is 97% less volatile than the S&P 500. Comparatively, Caribou Biosciences has a beta of 2.59, indicating that its share price is 159% more volatile than the S&P 500. Is TLPH or CRBU more profitable? Talphera has a net margin of 0.00% compared to Caribou Biosciences' net margin of -1,800.93%. Caribou Biosciences' return on equity of -62.35% beat Talphera's return on equity.Company Net Margins Return on Equity Return on Assets TalpheraN/A -152.38% -64.32% Caribou Biosciences -1,800.93%-62.35%-49.65% Does the media refer more to TLPH or CRBU? In the previous week, Talphera had 1 more articles in the media than Caribou Biosciences. MarketBeat recorded 4 mentions for Talphera and 3 mentions for Caribou Biosciences. Caribou Biosciences' average media sentiment score of 0.83 beat Talphera's score of 0.77 indicating that Caribou Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Talphera 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Caribou Biosciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryCaribou Biosciences beats Talphera on 9 of the 17 factors compared between the two stocks. Get Talphera News Delivered to You Automatically Sign up to receive the latest news and ratings for TLPH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TLPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLPH vs. The Competition Export to ExcelMetricTalpheraMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$56.07M$2.61B$6.05B$10.30BDividend YieldN/A57.78%5.73%4.82%P/E Ratio-2.9222.5785.3127.10Price / Sales82.06755.26601.46133.29Price / CashN/A26.3325.7730.18Price / Book2.495.3512.676.69Net Income-$13M$33.06M$3.32B$276.55M7 Day Performance6.36%0.94%-0.44%-1.14%1 Month Performance24.47%9.75%8.72%6.50%1 Year Performance48.10%-0.52%75.69%33.95% Talphera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLPHTalphera1.7541 of 5 stars$1.17-4.9%$5.00+327.4%+55.7%$56.07M$650K-2.9219Gap UpCRBUCaribou Biosciences2.185 of 5 stars$2.43+3.8%$6.67+174.3%+31.1%$226.28M$9.99M-1.37100BDTXBlack Diamond Therapeutics3.5207 of 5 stars$3.91-0.3%$11.00+181.3%+22.8%$222.62M$70M17.0090Positive NewsTRDAEntrada Therapeutics2.6699 of 5 stars$5.85-1.2%$25.67+338.7%-63.7%$222.53M$210.78M-3.29110Positive NewsNLTXNeoleukin TherapeuticsN/A$23.09+3.4%N/A-38.9%$217MN/A-7.4290High Trading VolumeEPRXEupraxia Pharmaceuticals2.7267 of 5 stars$6.02+0.7%$11.00+82.7%+152.9%$216.49MN/A-7.0829CLLSCellectis0.6543 of 5 stars$3.82+8.2%$4.00+4.7%+101.0%$212.33M$56.30M-4.66290Gap UpCABACabaletta Bio2.9702 of 5 stars$2.32-4.9%$14.50+525.0%-44.9%$212.20MN/A-0.8650Analyst ForecastGap UpTNXPTonix Pharmaceuticals2.6643 of 5 stars$23.00-5.0%$70.00+204.3%+43.6%$201.71M$10.09M-0.5850Gap DownBIOABioAge Labs0.182 of 5 stars$5.60-0.5%N/AN/A$200.76MN/A0.00N/ASLSSELLAS Life Sciences Group1.9702 of 5 stars$1.90+0.5%$7.00+268.4%+54.0%$200.07M$1M-5.9410News Coverage Related Companies and Tools Related Companies Caribou Biosciences Alternatives Black Diamond Therapeutics Alternatives Entrada Therapeutics Alternatives Neoleukin Therapeutics Alternatives Eupraxia Pharmaceuticals Alternatives Cellectis Alternatives Cabaletta Bio Alternatives Tonix Pharmaceuticals Alternatives BioAge Labs Alternatives SELLAS Life Sciences Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLPH) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talphera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talphera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
